Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073004 · ClinicalTrials.gov registry record · NA
RRT for PTSD Symptoms in Survivors of Sexual Violence
A NA study of PTSD and Rape Sexual Assault, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04073004: Completed NA study of PTSD and Rape Sexual Assault, sponsored by University of Colorado, Denver.
NCT04073004 is a NA study of PTSD and Rape Sexual Assault that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04073004, a NA study of PTSD and Rape Sexual Assault, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Study to provide evidence of efficacy for Rapid Resolution Therapy in symptoms of PTSD, Anxiety, and Depression in survivors of sexual violence.
Primary Outcome
The CAPS-5 is a 30-item structured interview that can be used to make current (past month) diagnosis of PTSD, make lifetime diagnosis of PTSD and assess PTSD symptoms over the past week In addition to assessing the 20 Diagnostic and Statistics Manual- 5th Edition (DSM-5) PTSD symptoms, questions target the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning, improvement in symptoms since a previous CAPS administration, overall response v
Conditions Studied
Interventions
- BEHAVIORAL Rapid Resolution Therapy
Study Locations (1)
Colorado
- University of Colorado at Denver counseling center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT04073004 record still lists
NCT04073004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Rapid Resolution Therapy is the first listed.
NCT04073004 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04073004 about?
NCT04073004 is a clinical study titled "RRT for PTSD Symptoms in Survivors of Sexual Violence". Study to provide evidence of efficacy for Rapid Resolution Therapy in symptoms of PTSD, Anxiety, and Depression in survivors of sexual violence.
What is the current status of trial NCT04073004?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-11-15. Estimated completion is 2023-06-30.
What conditions does trial NCT04073004 study?
This clinical trial studies the following conditions: PTSD, Rape Sexual Assault.
What interventions are being tested in trial NCT04073004?
The interventions under investigation include: Rapid Resolution Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04073004?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04073004 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04073004's enrollment target sits among peer trials
30 122nd of 154 higher than 25 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI